Skip to the page

Data / Form D filings / Zymeworks Inc.

Zymeworks Inc.: Form D filing

Zymeworks Inc., a biotechnology company in Middletown, DE, filed a Form D with the SEC in 2024. The latest, on January 3, 2024, reports $50 million sold of a $50 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
108 PATRIOT DRIVE, SUITE A, Middletown, DE, 19709
Phone
(302) 274-8744
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1937653

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 3, 2024New notice$50,000,502$49,999,993$5092Dec 28, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Hollings C. RentonDirector
Kenneth GalbraithExecutive Officer, Director
Carlos C. CampoyDirector
Susan M. MahonyDirector
Kelvin C. NeuDirector
Jeffrey C. SmithExecutive Officer
Paul C. MooreExecutive Officer
Troy M. CoxDirector
Nancy C. DavidsonDirector
Derek C. MillerDirector
Kenneth C. HillanDirector
Chris C. AstleExecutive Officer

Other biotechnology companies in Delaware that filed recently

Every Form D from the week of Jan 1, 2024 · All recent filings in Delaware · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Zymeworks Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.